Evidence map›Paper›PMID 10982361›Full record

ArticleJournal of virology2000

Putative immunodominant human immunodeficiency virus-specific CD8(+) T-cell responses cannot be predicted by major histocompatibility complex class I haplotype.

M R Betts, J P Casazza, B A Patterson, S Waldrop, W Trigona, T M Fu, F Kern, L J Picker, R A Koup

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Journal of virology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00027482 (Studies of Specific Immune Responses in HIV-Infected and HIV-Uninfected Volunteers), which is not on this map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00027482 completednot on this mapstarted 2001, after this paper: background citation

Studies of Specific Immune Responses in HIV-Infected and HIV-Uninfected Volunteers

TypeobservationalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran2001 to 2008Enrolled2,000ConditionsHealthy, HIV Infection
3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 150 citations in OpenAlex.

  1. Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects.Proceedings of the National Academy of Sciences of the United States of America · 2001
    Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Clonotype analysis of cytomegalovirus-specific cytotoxic T lymphocytes.Journal of the American Society of Nephrology : JASN · 2009
    Article
  18. Optimizing peptide matrices for identifying T-cell antigens.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2008
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

M R BettsDepartment of Internal Medicine, Division of Infectious Diseases, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
J P Casazza
B A Patterson
S Waldrop
W Trigona
T M Fu
F Kern
L J Picker
R A Koup
The University of Texas Southwestern Medical Center · USOregon Health & Science University · USUnited States Military Academy · USCharité - Universitätsmedizin Berlin · DE

Funding

VIROLOGY AND IMMUNOLOGY OF ACUTE HIV1 INFECTIONR01AI035522 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI PETERSON, DOLORES MURL · 1994 to 2006
$2.7M
MEMORY AND EFFECTOR CTL RESPONSES TO VIRUS INFECTIONSR01AI047603 · NIAID · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI KARANDIKAR, NITIN J · 1999 to 2002
$667k
VIROLOGY AND IMMUNOLOGY OF ACUTE HIV1 INFECTIONR37AI035522 · NIAID · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI KOUP, RICHARD A. · 1998 to 2000
$373k
NIAID NIH HHS AI35522NIAID NIH HHS AI47603NIAID NIH HHS R01 AI035522NIAID NIH HHS R01 AI047603NIAID NIH HHS R37 AI035522
6 · The paper itself

Abstract

Recent studies of human immunodeficiency virus (HIV)-specific CD8(+) T cells have focused on responses to single, usually HLA-A2-restricted epitopes as surrogate measures of the overall response to HIV. However, the assumption that a response to one epitope is representative of the total response is unconfirmed. Here we assess epitope immunodominance and HIV-specific CD8(+) T-cell response complexity using cytokine flow cytometry to examine CD8(+) T-cell responses in 11 HLA-A2(+) HIV(+) individuals. Initial studies demonstrated that only 4 of 11 patients recognized the putative immunodominant HLA-A2-restricted p17 epitope SLYNTVATL, suggesting that the remaining subjects might lack significant HIV-specific CD8(+) T-cell responses. However, five of six SLYNTVATL nonresponders recognized other HIV epitopes, and two of four SLYNTVATL responders had greater responses to HIV peptides restricted by other class I alleles. In several individuals, no HLA-A2-restricted epitopes were recognized, but CD8(+) T-cell responses were detected to epitopes restricted by other HLA class I alleles. These data indicate that an individual's overall CD8(+) T-cell response to HIV is not adequately represented by the response to a single epitope and that individual major histocompatibility complex class I alleles do not predict an immunodominant response restricted by that allele. Accurate quantification of total HIV-specific CD8(+) T-cell responses will require assessment of the response to all possible epitopes.

Indexed as

Antigen PresentationCD8-Positive T-LymphocytesCytotoxicity, ImmunologicHaplotypesHistocompatibility Antigens Class IHIV-1HIV InfectionsHumansHistocompatibility Antigens Class I

Identifiers

PMID10982361
PMCPMC102113
OpenAlexW2101588130

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.